0:00 【广交会首设智慧医疗专区，将引 入具身机器人等行业领先企业展出】10月10日下午，商务部举行第138届广交会专题新闻发布会。商务 部外贸司司长王志华表示，首设智慧医疗专区，吸引手术机器人、智能监测及可穿戴设备等47家企业参 加。引入46家行业领先企业，展出具身机器人、机器狗等，培育外贸发展新亮点。#21视频#详见： ...

Core Points - The 138th Canton Fair will be held from October 15 to November 4 in Guangzhou, featuring a total exhibition area of 1.55 million square meters and over 32,000 participating companies, both of which are historical highs [1][3] - A new highlight of this year's fair is the establishment of a Smart Medical Area, which will showcase advanced medical products and technologies, attracting 47 companies [3][4] Group 1: Event Overview - The Canton Fair will have a total of 74,600 exhibition booths, with approximately 3,600 companies participating for the first time [1] - The fair's online platform will continue to operate regularly, enhancing accessibility for global buyers [1] Group 2: Smart Medical Area - The Smart Medical Area will feature 140 booths and aims to promote products and technologies in the digital medical market, which is rapidly growing [3][4] - The showcased products will include medical robots, intelligent diagnostics, and smart rehabilitation care, facilitating connections with downstream industries [4] - The fair will provide immersive experiences and promote international collaboration, helping companies expand into global markets [4]

10月10日下午，商务部举行第138届广交会专题新闻发布会。商务部外贸司司长王志华表示，首设智慧 医疗专区，吸引手术机器人、智能监测及可穿戴设备等47家企业参加。引入46家行业领先企业，展出具 身机器人、机器狗等，培育外贸发展新亮点。此外，本届广交会首次举办外贸优品拓内销对接活动，设 置约3000平方米对接专区。还将举办超600场新品发布活动和13场主题论坛。截至目前，广交会全球合 作伙伴增至227家，覆盖110个国家和地区。 0:00 ...

Core Viewpoint - The stock price of Mindray Medical has experienced fluctuations, with a current price of 243.27 CNY per share, reflecting a year-to-date decline of 3.36% and a recent 5-day drop of 0.71% [1] Financial Performance - For the first half of 2025, Mindray Medical reported a revenue of 16.743 billion CNY, a year-on-year decrease of 18.45%, and a net profit attributable to shareholders of 5.069 billion CNY, down 32.96% compared to the previous year [2] - Cumulative cash dividends since the A-share listing amount to 33.699 billion CNY, with 23.388 billion CNY distributed over the last three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders for Mindray Medical is 91,600, a decrease of 0.68% from the previous period, with an average of 13,241 circulating shares per person, an increase of 0.69% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 131 million shares, a decrease of 3.0252 million shares from the previous period [3]

Core Insights - The health-related consumption sectors in Qinghai Province have shown robust growth, with a 16.3% year-on-year increase in invoiced sales revenue from January to August 2023, driven by enhanced health awareness among residents and an optimized consumption structure [1][3]. Group 1: Elderly and Child Care Services - The number of registered elderly care institutions in Qinghai reached 172 by the end of August, marking a 17.8% increase year-on-year, indicating a strengthening service system for elderly welfare [3]. - Revenue from various elderly care services grew by 5.5% year-on-year, reflecting a stable growth trend in this sector [3]. - The demand for childcare services, particularly nursery care, surged, with invoiced sales revenue from nursery services increasing by 23.2%, and the growth rate for childcare services reached 190% year-on-year [3]. Group 2: Health and Wellness Products - There was a notable increase in sales revenue for nutritional supplements and traditional Chinese medicine retail, with growth rates of 1.9% and 2% respectively [3]. - Revenue from health consultation and psychological services saw significant increases of 11.5% and 32.8% respectively, indicating a rising awareness of health and wellness among residents [3]. - The health insurance sector also experienced a 15.6% increase in invoiced sales revenue, further underscoring the growing focus on health-related expenditures [3]. Group 3: Smart Healthcare Development - The digital transformation in healthcare is advancing, with a 14.9% year-on-year increase in invoiced amounts for information technology services purchased by medical institutions [4]. - Sales revenue for smart health monitoring devices, such as smart wristbands and blood glucose monitors, surged by 74.3%, reflecting a heightened demand for daily health management tools among the public [4].

Group 1 - The core viewpoint of the article highlights the advancements in Tianjin's healthcare system, particularly through the implementation of smart hospital initiatives and enhanced appointment systems [2][3][4] - The Tianjin Oral Hospital has upgraded its appointment system, introducing features like "backup appointments" and zero-cost cross-department referrals, aimed at optimizing the limited appointment resources [2] - During the "14th Five-Year Plan" period, Tianjin is focusing on the construction of smart hospitals, which is gradually showing its support for clinical diagnosis, medical services, and hospital management [3] Group 2 - The Tianjin Eye Hospital has implemented a deep learning-based strabismus diagnosis and treatment assistance system, improving the efficiency and precision of strabismus treatment [4] - In January of this year, the Tianjin Health Commission announced 16 measures for health services by 2025, aimed at enhancing the public's experience in seeking medical care and promoting high-quality development of smart healthcare [4]

Core Insights - The company has successfully won a bid for multiple AI capability platform projects with Beijing Friendship Hospital, marking significant progress in the smart healthcare sector [1][2] - The project utilizes the company's self-developed medical large model and core technologies for multi-modal data recognition and governance, establishing an intelligent service platform for the hospital [1] - The implementation of this platform has led to substantial improvements in data value extraction and diagnostic efficiency, with specific examples including an 80% increase in medical record entry efficiency and a 15% reduction in consultation time [1] Industry Developments - This initiative aligns with national policies promoting AI empowerment in healthcare, transitioning smart healthcare from single-scenario intelligence to comprehensive digital solutions across the entire diagnosis and treatment process [2] - The company has reinforced its leading position in the healthcare intelligence competition, leveraging its advanced medical capabilities demonstrated in authoritative evaluations like MedBench and its experience with over 30% of top-tier hospitals nationwide [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 最新業務進展 本公告乃由雲知聲智能科技股份有限公司（「本公司」）自願作出，旨在知會本公司股東 及潛在投資者有關本公司的最新業務發展情況。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：9678） 自願性公告 於本公告日期，本公司董事會包括：(i)執行董事梁家恩博士、黃偉博士、康恒博士、李霄寒先生、劉升平先生及 李鵬先生；(ii)非執行董事鄺子平先生、李志超先生、汪存富先生及李昂先生；及(iii)獨立非執行董事胡建軍先生、 樊健先生、金慧華女士、張坤博士及陳華先生。 本公司董事會（「董事會」）欣然宣佈，本公司成功中標首都醫科大學北京友誼醫院（「北 京友誼醫院」）AI能力平台等多個智能體（Agent）項目，實現與北京友誼醫院在目前合作 基礎上服務關係的進一步深化，也標誌著本公司在智慧醫療領域的技術落地和商業 ...

Core Viewpoint - The stock of Weining Health has shown a significant increase in price this year, with a year-to-date rise of 31.42%, despite recent fluctuations in trading volume and net capital outflow [1][2]. Financial Performance - For the first half of 2025, Weining Health reported a revenue of 839 million yuan, representing a year-on-year decrease of 31.43%. The net profit attributable to shareholders was -118 million yuan, a significant decline of 491.04% compared to the previous year [2]. - Cumulatively, Weining Health has distributed 455 million yuan in dividends since its A-share listing, with 97.23 million yuan distributed over the last three years [3]. Shareholder Structure - As of September 19, 2025, the number of shareholders for Weining Health was 117,800, a decrease of 0.53% from the previous period. The average number of circulating shares per person increased by 0.53% to 16,244 shares [2]. - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF and E Fund Growth Enterprise Board ETF, with changes in their holdings noted [3].

Core Viewpoint - Aier Eye Hospital's stock price has shown fluctuations, with a recent increase of 2.03% on October 9, 2023, reaching 12.59 CNY per share, while the company has experienced a year-to-date decline of 3.83% [1] Financial Performance - For the first half of 2025, Aier Eye Hospital reported a revenue of 11.507 billion CNY, reflecting a year-on-year growth of 9.12%, and a net profit attributable to shareholders of 2.051 billion CNY, which is a slight increase of 0.05% [2] - Cumulative cash dividends since the company's A-share listing amount to 7.12 billion CNY, with 3.6 billion CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders decreased to 343,900, while the average circulating shares per person increased to 23,064 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 193 million shares, and several ETFs, with notable changes in their holdings [3] Market Activity - On October 9, 2023, the trading volume reached 635 million CNY, with a turnover rate of 0.65%, and a total market capitalization of 117.407 billion CNY [1] - The net inflow of main funds was 58.9952 million CNY, with significant buying and selling activities observed [1] Business Overview - Aier Eye Hospital, established on January 24, 2003, and listed on October 30, 2009, specializes in providing various ophthalmic medical services, with its main revenue sources being refractive projects (40.13%), vision services (23.64%), and cataract projects (15.48%) [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical services sector, and is involved in several concept sectors including medical aesthetics and private hospitals [1]